SPH SHANGHAI PHARMA
Live / Registered — Registered — Section 8 accepted (as of 08 Jan 2024)
What this means for you
Registered since 20 Mar 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86249647
- Registration number
- 5428633
- Mark type
- Design + words
- Filed
- 11 Apr 2014
- Published for opposition
- 09 Jun 2015
- Registered
- 20 Mar 2018
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS AND TRADITIONAL CHINESE MEDICINES USED AS PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS OF THE CARDIOVASCULAR SYSTEM, IMMUNE SYSTEM, METABOLIC SYSTEM AND GASTRO-INTESTINAL SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF NEUROPSYCHIATRIC DISEASES AND DISORDERS, VIRAL AND INFECTIOUS DISEASES, AND CANCER; PHARMACEUTICALS AND TRADITIONAL CHINESE MEDICINES USED AS PHARMACEUTICALS, NAMELY, ANTI-INFECTIVES AND ANTINEOPLASTICS
Owner
- Shanghai Pharmaceuticals Holding Co. Ltd., Shanghai, CN
- Shanghai Pharmaceuticals Holding Co. Ltd., Shanghai, CN
- Shanghai Pharmaceuticals Holding Co. Ltd., Shanghai, CN
Prosecution history
- 08 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Dec 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 08 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Dec 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Dec 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 08 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 08 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Oct 2023 — TEAS SECTION 8 RECEIVED
- 20 Mar 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Mar 2018 — REGISTERED-PRINCIPAL REGISTER
- 15 Feb 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Feb 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED